(40 MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP LIQUID

Maa: Kanada

Kieli: englanti

Lähde: Health Canada

Aktiivinen ainesosa:

SODIUM CHLORIDE; POTASSIUM CHLORIDE

Saatavilla:

BAXTER CORPORATION

ATC-koodi:

B05BB01

INN (Kansainvälinen yleisnimi):

ELECTROLYTES

Annos:

900MG; 300MG

Lääkemuoto:

LIQUID

Koostumus:

SODIUM CHLORIDE 900MG; POTASSIUM CHLORIDE 300MG

Antoreitti:

INTRAVENOUS

Kpl paketissa:

1000ML

Prescription tyyppi:

Ethical

Terapeuttinen alue:

REPLACEMENT PREPARATIONS

Tuoteyhteenveto:

Active ingredient group (AIG) number: 0213340002; AHFS:

Valtuutuksen tilan:

APPROVED

Valtuutus päivämäärä:

2012-12-10

Valmisteyhteenveto

Potassium Chloride in 0.9% Sodium Chloride Injection, USP Prescribing
Information
_ _
_Page 1 of 15_
PRESCRIBING INFORMATION
POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION, USP
IN PLASTIC CONTAINER
VIAFLEX
Container
20mmol/L Potassium Chloride in Sodium in 0.9% Chloride Injection
40mmol/L Potassium Chloride in Sodium in 0.9% Chloride Injection
SOLUTION FOR INFUSION
Solutions Affecting the Electrolyte Balance
BAXTER CORPORATION
Mississauga, ON L5N 0C2
Date of Revision:
December 10, 2018
Control No. 221539
Potassium Chloride in 0.9% Sodium Chloride Injection, USP Prescribing
Information
_ _
_Page 2 of 15_
TABLE OF CONTENTS
SUMMARY PRODUCT INFORMATION
........................................................................3
INDICATIONS AND CLINICAL USE
..............................................................................3
CONTRAINDICATIONS
...................................................................................................3
WARNINGS AND PRECAUTIONS
..................................................................................3
ADVERSE REACTIONS
....................................................................................................8
DRUG INTERACTIONS
....................................................................................................9
DOSAGE AND ADMINISTRATION
..............................................................................10
INSTRUCTIONS FOR USE AND HANDLING AND DISPOSAL
................................11
DIRECTIONS FOR USE OF VIAFLEX PLUS PLASTIC CONTAINER
......................11
OVERDOSE
......................................................................................................................12
ACTION AND CLINICAL PHARMACOLOGY
............................................................13
STORAGE AND STABILITY
..........................................................................................13
DOSAGE FORMS, COMPOSITION AND PACKAGING
.............................................13
Potassium Chloride in 0.9% Sodium Chlo